PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.690.03 (-4.17%)
0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.16%
Revenue growth under 50% of 0259.HK's 4.76%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
20.10%
Gross profit growth above 1.5x 0259.HK's 1.66%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
8.18%
EBIT growth 1.25-1.5x 0259.HK's 6.44%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
8.18%
Operating income growth above 1.5x 0259.HK's 0.60%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
85.09%
Net income growth above 1.5x 0259.HK's 19.01%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
84.38%
EPS growth above 1.5x 0259.HK's 25.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
85.94%
Diluted EPS growth above 1.5x 0259.HK's 25.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-6.85%
Share reduction while 0259.HK is at 0.41%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
1.22%
Diluted share count expanding well above 0259.HK's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
6.96%
Maintaining or increasing dividends while 0259.HK cut them. John Neff might see a strong edge in shareholder returns.
-10.98%
Negative OCF growth while 0259.HK is at 39.81%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-15.47%
Negative FCF growth while 0259.HK is at 247.79%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-35.10%
Negative 10Y revenue/share CAGR while 0259.HK stands at 79.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-46.64%
Negative 5Y CAGR while 0259.HK stands at 52.27%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.46%
Negative 3Y CAGR while 0259.HK stands at 55.51%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-8146.73%
Negative 10Y OCF/share CAGR while 0259.HK stands at 18.29%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
36.76%
5Y OCF/share CAGR above 1.5x 0259.HK's 8.65%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-85.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-196.54%
Negative 10Y net income/share CAGR while 0259.HK is at 220.38%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-102.54%
Negative 5Y net income/share CAGR while 0259.HK is 93.77%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-108.70%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
88.86%
10Y equity/share CAGR above 1.5x 0259.HK's 46.24%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-3.72%
Negative 5Y equity/share growth while 0259.HK is at 56.18%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-12.03%
Negative 3Y equity/share growth while 0259.HK is at 28.26%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-18.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.37%
Our AR growth while 0259.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
20.84%
Inventory growth well above 0259.HK's 5.12%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.58%
Asset growth well under 50% of 0259.HK's 7.31%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.91%
50-75% of 0259.HK's 8.78%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-3.03%
We’re deleveraging while 0259.HK stands at 13.86%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
146.15%
R&D growth of 146.15% while 0259.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-18.01%
We cut SG&A while 0259.HK invests at 2.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.